Product Categories
| Country: | China |
|---|---|
| Tel: | 020-61855200 |
| Mobile: | 18124244216 |
| E-mail: | info@upharm.cn |
| QQ: | 2885627074 |
| Skype: | Chat Now! |
| Address: | 12th floor, No. 181, Kexue Avenue, Huangpu District |
|
Tosun United Pharma and Group is committed to making due contributions to the cause of human health. At present, the group holds two wholly-owned subsidiaries: Guangzhou Tosun Pharmaceutical Co., Ltd. and Guangzhou Tosun-Bridge Pharm and Tech Ltd.
Guangzhou Tosun Pharmaceutical Co., Ltd.is a GSP (CRO) company that meets the requirements of modern management. It is the leader in the field of exporting and importing of APIs, excipients, prescriptions and impurities. In the past 20 years, the company has always adhered to the business philosophy of 'innovation, professional, integrity and self-discipline', and has a professional marketing team. Our sales network covering over 500 manufactures and work over 1000 products. With more than 1500 Clients from global market.
Tosun Pharma's main business covers from academic promotion and sales of preparations to sales and agents of preparations, APIs and chemical intermediates. It has the right of self import and export of the above products. At present, it acts as an agent for more than 30 imported raw materials, 30 agent preparations and more than 50 registration certificates of imported drugs being declared.
Guangzhou Juntai Medical Technology Co., Ltd. is a third-party technical service platform company under Tosun and United Pharmaceutical Group. It provides customers with professional one-stop solutions for pharmaceutical research and development, clinical pre BE and clinical BE. At present, the key businesses mainly include: API joint declaration, one-time import of reference preparation, clinical pre BE / formal BE and consistency evaluation service.
|
|
| Product Name | MF | CAS | Details |
|---|
| Mesalazine EP Impurity K | C6H7N | 62-53-3 | Details |
| Rifapentine impurity 6 | C4H12N4 | Details |
| 3-N-Butylphthalide | C12H14O2 | 6066-49-5 | Details |
| 2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3 | C30H50O5 | 104121-92-8 | Details |
| 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide | C14H22ClN3O2 | 364-62-5 | Details |
| 5-Methyl-2-phenyl-1,2-dihydropyrazol-3-one | C10H10N2O | 89-25-8 | Details |
| Allopregnanolone | C21H34O2 | 516-54-1 | Details |
| Adefovir dipivoxil | C20H32N5O8P | 142340-99-6 | Details |
| Alfacalcidol | C27H44O2 | 41294-56-8 | Details |
| Afatinib dimaleate | C28H29ClFN5O7 | 850140-73-7 | Details |
| AZASETRON HYDROCHLORIDE | C17H21Cl2N3O3 | 141922-90-9 | Details |
| Apraclonidine hydrochloride | C9H11Cl3N4 | 73218-79-8 | Details |
| Ammonium acetate | C2H7NO2 | 631-61-8 | Details |
| Aripiprazole | C23H27Cl2N3O2 | 129722-12-9 | Details |
| Benoxinate Hydrochloride | C17H29ClN2O3 | 5987-82-6 | Details |
| Aprepitant | C23H21F7N4O3 | 170729-80-3 | Details |
| BEPOTASTINE BESILATE | C27H31ClN2O6S | 190786-44-8 | Details |
| Brinzolamide | C12H21N3O5S3 | 138890-62-7 | Details |
| Anastrozole | C17H19N5 | 120511-73-1 | Details |
| Calcipotriene | C27H40O3 | 112965-21-6 | Details |
| Bromfenac Sodium | C15H11BrNNaO3 | 120638-55-3 | Details |
| Bupivacaine Hydrochloride | C18H31ClN2O2 | 73360-54-0 | Details |
| Brexpiprazole | C25H27N3O2S | 913611-97-9 | Details |
| Apalutamide | C21H15F4N5O2S | 956104-40-8 | Details |
| Calcitriol | C27H44O3 | 32222-06-3 | Details |
| Brivaracetam | C11H20N2O2 | 357336-20-0 | Details |
| Calcium chloride dihydrate | CaCl2H4O2 | 10035-04-8 | Details |
| Posaconazole Impurity 229 | Details |
| Orciprenaline EP Impurity B | C11H15NO3 | 94200-14-3 | Details |
| Pyronoprene Impurity 24 | C22H16N2O | 380918-51-4 | Details |
| Pyronoprene Impurity 3 | C23H17N3O2 | 380919-34-6 | Details |
| Zinc Gluconate | C12H22O14Zn | 4468-02-4 | Details |
| Urosodeoxycholic Acid EP Impurity F(Obeticholic Acid Intermediate 1) | C24H38O4 | 4651-67-6 | Details |
| Tolvaptan Impurity 10 | C18H17ClN2O2 | 137977-97-0 | Details |
| Carbetocin | C45H69N11O12S | 37025-55-1 | Details |
| Tetracaine(Oxybuprocaine)EP Impurity A(Benzocaine EP impurity G) | C7H7NO2 | 150-13-0 | Details |
| Tolvaptan Impurity 8 | C26H23ClN2O3 | 137973-76-3 | Details |
| Procaterol Impurity 4 | C16H20N2O3 | 63235-39-2 | Details |
| Cariprazine hydrochloride | C21H33Cl3N4O | 1083076-69-0 | Details |
| Celecoxib | C17H14F3N3O2S | 169590-42-5 | Details |
| Paliperidone Impurity 80 | Details |
| Dapagliflozin propanediol monohydrate | C24H33ClO8 | 960404-48-2 | Details |
| Cetirizine dihydrochloride | C21H26Cl2N2O3 | 83881-52-1 | Details |
| Altrenogest | C21H26O2 | 850-52-2 | Details |
| Tamsulosin Impurity 20 | C17H22N2O3S.ClH | 622853-25-2 | Details |
| Tamsulosin Impurity 21 | C9H14N2O3S.ClH | 622853-26-3 | Details |
| Tamsulosin Impurity 2 | C20H28N2O5S | 116091-64-6 | Details |
| Rifapentine impurity 1 | C45H62N4O11 | 79039-56-8 | Details |
| Salbutamol Sulfate EP Impurity K | C13H18ClNO3 | 898542-80-8 | Details |
| Salbutamol Impurity 21 | C13H17NO3 | 115787-52-5 | Details |
| Sitagliptin Impurity 13 | C16H12F6N4O2 | 764667-65-4 | Details |
| Sitagliptin Impurity 18 | C6H7F3N4.ClH | 762240-92-6 | Details |
| Roxtidine Oxalate | C19H28N2O7 | 110925-92-3 | Details |
| Lenvatinib Impurity 56 | C10H11ClN2O2 | Details |
| Loxoprofen Impurity 61 | C10H14O | Details |
| Lomustine EP impurity C | C13H24N2O | 2387-23-7 | Details |
| Sitagliptin Impurity 14 | C16H13F6N5O | 767340-03-4 | Details |
| Salbutamol Impurity 03HCl | C13H22ClNO2 | 70334-18-8 | Details |
| Methotrexate Impurity 21 | C7H8Cl2N6 | 82778-08-3 | Details |
| Paliperidone Impurity 22 | Details |
| Osteltamivir Phosphate | C16H31N2O8P | 204255-11-8 | Details |
| Methotrexate Impurity 43 | C15H19N3O9 | Details |
| Mometasone Furoate Impurity L(Dexamethasone EP Impurity D) | C22H28O5 | 24916-90-3 | Details |
| Neratinib Impurity 14 | C26H22ClN5O3 | 915941-95-6 | Details |
| Norepinephrine Impurity 54 | C10H9BrO3 | Details |
| Phenylephrine Impurity 12 | C9H13NO2 | Details |
| Paliperidone Impurity 81 | Details |
| Paliperidone Impurity 74 | C24H27FN4O3 | 1204315-39-8 | Details |
| Phenylephrine Impurity 13 | C13H17NO6 | Details |
| N,N-Dimethylformamide | C3H7NO | 68-12-2 | Details |
| afoxolaner | C26H17ClF9N3O3 | 1093861-60-9 | Details |
| Paliperidone Impurity 70 | Details |
| Norepinephrine Impurity 30 | C8H11NO3 | Details |
| Mycophenolate Mofetil EP Impurity D | C24H33NO7 | 1322681-37-7 | Details |
| O-Desacetyl Diltiazem N-Oxide | C20H24N2O4S | 122619-90-3 | Details |
| Paliperidone Impurity 46 | Details |
| Methotrexate impurity 30 | C9H12N2O | 942840-87-1 | Details |
| Tamsulosin Impurity 1 | C10H14N2O4S | 944395-49-7 | Details |
| Paliperidone Impurity 75 | C12H13F2NO | Details |
| Urosodeoxycholic Acid Impurity 37 | Details |
| Trazodone Impurity 28 | C17H20ClN5O | Details |
| Arteparon | 63449-40-1 | Details |
| Benzenamine, 2,6-dichloro-4-[3-(1,1-dimethylethyl)-5-oxazolidinyl]-, hydrochloride (1:) | C13H19Cl3N2O | 50617-63-5 | Details |
| 7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-1,2,3,4-tetrahydroquinolin-2-one hydrate | C23H29Cl2N3O3 | 851220-85-4 | Details |
| Paliperidone Impurity 71 | C23H28N4O4 | Details |
| Paliperidone Impurity 73 | Details |
| N-desmethyl diltiazem hydrochloride (diltiazem impurity 17) | C21H24N2O4S | 86408-45-9 | Details |
| Paliperidone Impurity 67 | C12H15ClN2O2 | 1160611-32-4 | Details |
| Lysine impurity 4 | C10H18N2O4 | 499-86-5 | Details |
| Lornoxicam Impurity 88 | Details |
| Ranolazine impurity 3 | 2731041-97-5 | Details |
| Unknown impurity 3 (separation and purification) | Details |
| Tamsulosin Impurity 6 | C20H28ClNO3 | 2724727-12-0 | Details |
| Levofolinate Impurity 14 | Details |
| Methotrexate Impurity 39 | C22H26N8O5 | Details |
| Lenvatinib Impurity 55 | C10H11NO2 | Details |
| Tamsulosin Impurity 26 | C19H24O4 | 420098-07-3 | Details |
| Lornoxicam Impurity 9 | C5H4ClNO4S2 | 1017791-22-8 | Details |
| Sodium chloride designation | Details |
| allyl chlorooxoacetate | C5H5ClO3 | 74503-07-4 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 | ||||